Rainbow Childrens Medicare reports strong financial results for Q3 2024, with significant growth in PBT and PAT

Rainbow Childrens Medicare, a midcap hospital and healthcare services company, has recently announced its financial results for the quarter ending September 2024. The company has shown a positive performance in this quarter, with a significant improvement in its financial score from -14 to 10 in the last three months.

One of the key highlights of the financial results is the growth in Profit Before Tax (PBT) and Profit After Tax (PAT). The PBT has grown by 49.7% to Rs 94.08 crore, while the PAT has increased by 46.4% to Rs 78.87 crore, compared to the average of the previous four quarters. This indicates a very positive trend in the near term for the company.

Another positive aspect is the increase in net sales, which has reached its highest at Rs 417.46 crore in the last five quarters. This shows a growth of 24.6% over the average net sales of the previous four quarters. The company's operating profit (PBDIT) has also shown a positive trend, reaching its highest at Rs 147.08 crore in the last five quarters.

Rainbow Childrens Medicare has also reported its highest earnings per share (EPS) at Rs 7.77 in the last five quarters, indicating an increase in profitability and creating higher earnings for shareholders.

However, there are some areas that need improvement, as seen in the financial results. The interest cost has increased by 25.82% over the preceding nine months period, indicating a rise in borrowings. The company's debtors turnover ratio has also decreased to its lowest at 15.02 times in the last five half-yearly periods, showing a slower pace in settling its debtors.

Overall, Rainbow Childrens Medicare has shown a positive and promising financial performance in the quarter ending September 2024. With a 'Buy' call from MarketsMOJO, the company is expected to continue its growth and success in the hospital and healthcare services industry.